PulmoBioMed  – a Northumbria University spinout which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4 million to help commercialise its technology and target the US market. The investment round was led by the North East Venture Fund, supported by the European Regional … Continue reading Spinout raises £1.4m to aid early diagnosis of asthma